Lisocabtagene maraleucel delivers sustained survival benefits and long-term disease control in relapsed or refractory LBCL.

At the surface, the immune response to a flu virus is simple. Some cells recognize the pathogen and send a signal to the ...

Learn more about the research of Mayo Clinic's Gene Editing and Cellular Engineering Laboratory led by David (Chun-Wei) D.

Teclistamab-cqyv (Tecvayli) led to clinically meaningful responses in patients with heavily pretreated multiple myeloma who ...

At the surface, the immune response to a flu virus is simple. Some cells recognize the pathogen and send a signal to the ...

This new article publication from Acta Pharmaceutica Sinica B, discusses how melatonin receptor 1a alleviates sleep fragmentation-aggravated testicular injury in T2DM by suppression of TAB1/TAK1 ...

Allogeneic cell therapies are advancing in clinical trials, requiring oncologists and pathologists to understand the ...